Uncategorized Archives - Page 4 of 87 - PsychedelicNewsWire (PNW)

ThursdaySep 07, 2023 9:30 am

The Strategic Brilliance of Acquiring High Times IP, Including Existing Licensing Agreements and Royalty Streams in All-Stock Transaction

Lucy Scientific Beats MindMed and Seelos Therapeutics to the Punch Lucy Scientific Discovery (NASDAQ: LSDI) (“Lucy” or the “Company), a Nasdaq-listed company with holdings and operations in a variety of psychotropic businesses, just announced the acquisition of the Intellectual Property of High Times, its Licensing Agreements and Royalty Streams in all-stock transaction. This was a brilliant strategic business move. With first movers in the “Mind Science” space like MindMed (NASDAQ: MNMD) and Seelos Therapeutics (NASDAQ: SEEL) realizing than 80% and 40% year-to-date gains respectively, today’s acquisition by Lucy delivers immediate revenue, an expanded product line, a proven and highly influential…

WednesdayJun 21, 2023 1:33 pm

Canadian Study Shows Lower Substance Abuse Cases Among Psychedelics Users

A Canadian research team has published findings indicating that psychedelic use may lower substance abuse rates among users. The study, whose findings were reported in the “International Journal of Mental Health and Addiction,” sought to understand changes in patterns of substance abuse among Canadians after they took psychedelics. As in the United States and Australia, Canada has loosened its psychedelic policies in recent years to finally allow researchers to study their potential benefits and risks. These preliminary studies have revealed that several psychedelics can alleviate the symptoms of mental disorders, such as eating disorders, treatment-resistant depression, anxiety and PTSD. As…

FridayMay 26, 2023 10:30 am

The Green Label Expo: Las Vegas 2023 Edition

The Green Label Expo 2023 edition will be held at the World Market Center in Las Vegas on the 13th & 14th of September, welcoming thousands of CBD experts, alternative product professionals, counterculture experts, and business owners to discover a vast array of global suppliers in trending sectors such as beauty, health & wellness, pet products, foods, business services, and more. As the need for embracing alternative products surges, the vibrant city of Las Vegas is set to welcome the largest trade show for CBD and alternative product professionals. This two-day event will feature an extensive showcase of innovative products/services,…

MondayMay 22, 2023 12:06 pm

More Firms Enter Psychedelic Field to Develop Mental Health Treatments

Psychedelic reform is gaining traction in the United States as more states introduce measures to decriminalize and legalize the use of these substances. This is primarily due to a significant increase of interest in these drugs in the recent years as more studies uncover the therapeutic benefits that psychedelics possess. Thus far, numerous studies have found that psychedelics such as MDMA, psilocybin and ketamine may help manage symptoms of anxiety and depression, reduce OCD symptoms, improve mood and improve symptoms of post-traumatic stress disorder. In 2017, the FDA even granted breakthrough therapy designations to psychedelic therapies using psilocybin to treat…

ThursdayMay 18, 2023 3:19 pm

Five Scientific Discoveries about Psychedelic Substances, Their Effects

Interest in psychedelics has increased significantly in recent years, with numerous studies being conducted on DMT, MDMA, LSD and psilocybin mushrooms. These substances are known to alter cognition, perception and mood when consumed, with researchers finding that they also possess therapeutic benefits that may be useful in the treatment of mental health conditions such as anxiety, depression, addiction and PTSD. Today, we look at some of the discoveries related to psychedelic drugs and their therapeutic potential. Psychedelics may help manage alcohol abuse. One study has determined that a combination of 5-MeO-DMT and ibogaine treatments may help reduce symptoms of PTSD…

MondayMay 08, 2023 3:38 pm

Study Looks into Neurobiology of Psychedelics

Since the late 19th century, physicians have used laughing gas as an anesthetic. Laughing gas, or nitrous oxide as it is scientifically known as, was first discovered by Joseph Priestly, an English scientist in 1793. This colorless, odorless and nonflammable gas is known to produce mind-altering experiences when administered in small amounts, similar to states induced by psychedelics such as ketamine and LSD. New research has looked into how nitrous oxide affects brain activity and how similar its effects are to those of psychedelics. The study was led by Richard Harris and George Mashour of the Michigan Psychedelic Center at…

FridayApr 28, 2023 2:22 pm

Challenges Facing European Psychedelics Industry

Psychedelics are hallucinogenic drugs that induce temporary alterations in mood, perception and mental processes in an individual when ingested. These drugs can occur naturally, such as psilocybin, or be manufactured in a lab, such as LSD, which was first synthesized by Albert Hoffman in 1938. Before psychedelics were classified under Schedule 1 of the 1971 UN Convention on Psychotropic Drugs, the drugs were used to manage various symptoms and psychiatric issues. This classification was brought on mainly by the growing hostility of sociopolitical views regarding the use of drugs as well as the covert and unethical use of said drugs.…

TuesdayMar 28, 2023 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Provides Update on Innovative Study Looking into the Feasibility of Using Ketamine Formulations as an Alternative Treatment for Fibromyalgia

Silo Pharma recently provided an update on an ongoing study delving into the potential use of SP-26 as an alternative treatment for fibromyalgia The study, which is being carried out in conjunction with Experimur, has looked into the feasibility of using a time-released, dosage-controlled formulation of ketamine as a suitable treatment for the chronic medical condition Since its founding, Silo Pharma has rapidly gained a reputation for its innovative approach towards seeking solutions to address a variety of underserved medical conditions Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused around merging traditional therapeutics with psychedelic research, recently announced…

MondayMar 13, 2023 10:30 am

Silo Pharma Inc. (NASDAQ: SILO) Set to Benefit as Study Supports the Efficacy of Psychedelics in Treating ‘Drug-Resistant’ Depression

A recent medical study found that psychedelic drugs showed promise as a treatment alternative for hard-to-treat depression Psychedelics were found to activate a greater number of serotonin 2A receptors then traditional antidepressant drugs, largely because of their ability to penetrated through cells’ fatty outer membranes The study reinforces the potential use of psychedelic drugs, and psilocybin in particular, as a treatment methodology for a variety of mental health related conditions Silo Pharma, a developmental stage biopharmaceutical company has long focused around merging traditional therapeutics with psychedelic research In a study carried out between 2013 to 2016, researchers found that 8.1%…

WednesdayFeb 22, 2023 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced Disorders

SILO issued US Patent by USPTO titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females” Claims allowed by patent protect use of SPC-15 for treating stress-induced affective disorders, including anxiety and PTSD Other therapeutics in company pipeline include SPU-16 to treat multiple sclerosis, SPU-21 to treat rheumatoid arthritis, SPC-14 to treat Alzheimer’s disease Therapeutics developed by SILO may qualify for FDA’s streamlined 505(b)(2) regulatory drug approval pathway Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, was recently issued US Patent 11,491,120 by the US Patent and Trademark Office (“USPTO”) (https://ibn.fm/rMLOR). The…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized